Loading insider details...
Beta
Latest Form 4 (Aug 5, 2026): Grant/Award of 37,653 OBX shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Aug 5, 2026 | Obsidian Therapeutics, Inc. (OBX) | Grant/Award | 37,653 | n/a |
| Oct 17, 2024 | Generation Bio Co. (GBIO) | Exercise/Conversion | 1,674 | n/a |
| Jul 17, 2024 | Generation Bio Co. (GBIO) | Exercise/Conversion | 1,674 | n/a |
| Apr 17, 2024 | Generation Bio Co. (GBIO) | Exercise/Conversion | 1,674 | n/a |
| Jan 17, 2024 | Generation Bio Co. (GBIO) | Exercise/Conversion | 7,437 | n/a |
| Jan 3, 2024 | Generation Bio Co. (GBIO) | Grant/Award | 160,650 | n/a |
| Dec 5, 2023 | Generation Bio Co. (GBIO) | Grant/Award | 76,310 | n/a |
| Oct 17, 2023 | Generation Bio Co. (GBIO) | Exercise/Conversion | 7,437 | n/a |
| Jul 18, 2023 | Generation Bio Co. (GBIO) | Exercise/Conversion | 7,437 | n/a |
| Apr 18, 2023 | Generation Bio Co. (GBIO) | Exercise/Conversion | 7,437 | n/a |